Stock Analysis on Net

Becton, Dickinson & Co. (NYSE:BDX)

This company has been moved to the archive! The financial data has not been updated since May 5, 2022.

Common Stock Valuation Ratios (Price Multiples) 

Microsoft Excel

Current Valuation Ratios

Becton, Dickinson & Co., current price multiples

Microsoft Excel
Becton, Dickinson & Co. Abbott Laboratories Cigna Group CVS Health Corp. Elevance Health Inc. Humana Inc. Intuitive Surgical Inc. Medtronic PLC UnitedHealth Group Inc. Health Care Equipment & Services Health Care
Selected Financial Data
Current share price (P) $259.64
No. shares of common stock outstanding 285,064,629
Growth rate (g) 1.53%
 
Earnings per share (EPS) $7.02
Next year expected EPS $7.13
Operating profit per share $9.82
Sales per share $71.03
Book value per share (BVPS) $83.06
Valuation Ratios (Price Multiples)
Price to earnings (P/E) 36.97 35.13 17.42 8.57 15.40 14.22 107.33 29.34 24.69 25.85 22.17
Price to next year expected earnings 36.41 32.88 15.64 8.08 13.69 12.11 94.57 28.82 21.06 23.43 20.07
Price-earnings-growth (PEG) 24.19 5.11 1.53 1.40 1.23 0.81 7.95 16.01 1.43 2.51 2.12
Price to operating profit (P/OP) 26.44 31.04 10.54 5.20 12.11 8.82 109.23 20.97 17.08 19.19 18.45
Price to sales (P/S) 3.66 5.01 0.46 0.20 0.54 0.34 27.09 3.33 1.50 1.28 2.54
Price to book value (P/BV) 3.13 5.21 1.95 0.94 2.35 2.18 14.50 2.15 6.23 3.89 5.33

Based on: 10-K (reporting date: 2021-09-30).

If the company price multiple is lower then the price multiple of benchmark then company stock is relatively undervalued.
Otherwise, if the company price multiple is higher then the price multiple of benchmark then company stock is relatively overvalued.


Historical Valuation Ratios (Summary)

Becton, Dickinson & Co., historical price multiples

Microsoft Excel
Sep 30, 2021 Sep 30, 2020 Sep 30, 2019 Sep 30, 2018 Sep 30, 2017 Sep 30, 2016
Price to earnings (P/E) 34.68 86.01 65.09 408.36 49.63 36.65
Price to operating profit (P/OP) 24.81 44.46 40.02 43.37 34.59 25.02
Price to sales (P/S) 3.43 3.85 4.07 4.06 4.23 2.87
Price to book value (P/BV) 2.93 2.78 3.34 3.09 3.95 4.69

Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).

Valuation ratio Description The company
P/E ratio The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings. Becton, Dickinson & Co. P/E ratio increased from 2019 to 2020 but then decreased significantly from 2020 to 2021.
P/OP ratio Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit. Becton, Dickinson & Co. P/OP ratio increased from 2019 to 2020 but then decreased significantly from 2020 to 2021.
P/S ratio An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative. Becton, Dickinson & Co. P/S ratio decreased from 2019 to 2020 and from 2020 to 2021.
P/BV ratio The P/BV ratio is interpreted as an indicator of market judgment about the relationship between a company required rate of return and its actual rate of return. Becton, Dickinson & Co. P/BV ratio decreased from 2019 to 2020 but then slightly increased from 2020 to 2021.

Price to Earnings (P/E)

Becton, Dickinson & Co., historical P/E calculation, comparison to benchmarks

Microsoft Excel
Sep 30, 2021 Sep 30, 2020 Sep 30, 2019 Sep 30, 2018 Sep 30, 2017 Sep 30, 2016
No. shares of common stock outstanding1 284,023,582 290,031,363 270,459,892 268,257,940 227,978,328 212,319,588
Selected Financial Data (US$)
Net income applicable to common shareholders (in millions) 2,002 767 1,082 159 1,030 976
Earnings per share (EPS)2 7.05 2.64 4.00 0.59 4.52 4.60
Share price1, 3 244.46 227.47 260.40 242.04 224.23 168.48
Valuation Ratio
P/E ratio4 34.68 86.01 65.09 408.36 49.63 36.65
Benchmarks
P/E Ratio, Competitors5
Abbott Laboratories 29.13 48.49 41.83
Cigna Group 13.43 8.71 13.26
CVS Health Corp. 17.39 12.88 14.15
Elevance Health Inc. 18.13 15.87 15.96
Humana Inc. 18.34 14.48 18.10
Intuitive Surgical Inc. 59.94 87.47 48.72
Medtronic PLC 46.56 26.30 28.78
UnitedHealth Group Inc. 26.03 20.54 20.48
P/E Ratio, Sector
Health Care Equipment & Services 25.01 21.10 21.63
P/E Ratio, Industry
Health Care 19.87 29.50 21.10

Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).

1 Data adjusted for splits and stock dividends.

2 2021 Calculation
EPS = Net income applicable to common shareholders ÷ No. shares of common stock outstanding
= 2,002,000,000 ÷ 284,023,582 = 7.05

3 Closing price as at the filing date of Becton, Dickinson & Co. Annual Report.

4 2021 Calculation
P/E ratio = Share price ÷ EPS
= 244.46 ÷ 7.05 = 34.68

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/E ratio The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings. Becton, Dickinson & Co. P/E ratio increased from 2019 to 2020 but then decreased significantly from 2020 to 2021.

Price to Operating Profit (P/OP)

Becton, Dickinson & Co., historical P/OP calculation, comparison to benchmarks

Microsoft Excel
Sep 30, 2021 Sep 30, 2020 Sep 30, 2019 Sep 30, 2018 Sep 30, 2017 Sep 30, 2016
No. shares of common stock outstanding1 284,023,582 290,031,363 270,459,892 268,257,940 227,978,328 212,319,588
Selected Financial Data (US$)
Operating income (in millions) 2,799 1,484 1,760 1,497 1,478 1,430
Operating profit per share2 9.85 5.12 6.51 5.58 6.48 6.74
Share price1, 3 244.46 227.47 260.40 242.04 224.23 168.48
Valuation Ratio
P/OP ratio4 24.81 44.46 40.02 43.37 34.59 25.02
Benchmarks
P/OP Ratio, Competitors5
Abbott Laboratories 24.45 40.69 34.03
Cigna Group 9.08 9.03 8.38
CVS Health Corp. 10.43 6.65 7.83
Elevance Health Inc. 15.70 12.10 13.55
Humana Inc. 17.08 9.78 15.35
Intuitive Surgical Inc. 56.11 88.37 48.89
Medtronic PLC 37.44 26.29 21.26
UnitedHealth Group Inc. 18.77 14.12 14.40
P/OP Ratio, Sector
Health Care Equipment & Services 18.57 15.61 15.23
P/OP Ratio, Industry
Health Care 16.54 21.85 17.29

Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).

1 Data adjusted for splits and stock dividends.

2 2021 Calculation
Operating profit per share = Operating income ÷ No. shares of common stock outstanding
= 2,799,000,000 ÷ 284,023,582 = 9.85

3 Closing price as at the filing date of Becton, Dickinson & Co. Annual Report.

4 2021 Calculation
P/OP ratio = Share price ÷ Operating profit per share
= 244.46 ÷ 9.85 = 24.81

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/OP ratio Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit. Becton, Dickinson & Co. P/OP ratio increased from 2019 to 2020 but then decreased significantly from 2020 to 2021.

Price to Sales (P/S)

Becton, Dickinson & Co., historical P/S calculation, comparison to benchmarks

Microsoft Excel
Sep 30, 2021 Sep 30, 2020 Sep 30, 2019 Sep 30, 2018 Sep 30, 2017 Sep 30, 2016
No. shares of common stock outstanding1 284,023,582 290,031,363 270,459,892 268,257,940 227,978,328 212,319,588
Selected Financial Data (US$)
Revenues (in millions) 20,248 17,117 17,290 15,983 12,093 12,483
Sales per share2 71.29 59.02 63.93 59.58 53.04 58.79
Share price1, 3 244.46 227.47 260.40 242.04 224.23 168.48
Valuation Ratio
P/S ratio4 3.43 3.85 4.07 4.06 4.23 2.87
Benchmarks
P/S Ratio, Competitors5
Abbott Laboratories 4.78 6.30 4.83
Cigna Group 0.42 0.46 0.44
CVS Health Corp. 0.47 0.35 0.37
Elevance Health Inc. 0.81 0.60 0.74
Humana Inc. 0.65 0.64 0.76
Intuitive Surgical Inc. 17.89 21.29 15.01
Medtronic PLC 5.57 4.36 4.36
UnitedHealth Group Inc. 1.58 1.24 1.18
P/S Ratio, Sector
Health Care Equipment & Services 1.24 1.10 1.05
P/S Ratio, Industry
Health Care 2.28 2.25 2.13

Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).

1 Data adjusted for splits and stock dividends.

2 2021 Calculation
Sales per share = Revenues ÷ No. shares of common stock outstanding
= 20,248,000,000 ÷ 284,023,582 = 71.29

3 Closing price as at the filing date of Becton, Dickinson & Co. Annual Report.

4 2021 Calculation
P/S ratio = Share price ÷ Sales per share
= 244.46 ÷ 71.29 = 3.43

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/S ratio An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative. Becton, Dickinson & Co. P/S ratio decreased from 2019 to 2020 and from 2020 to 2021.

Price to Book Value (P/BV)

Becton, Dickinson & Co., historical P/BV calculation, comparison to benchmarks

Microsoft Excel
Sep 30, 2021 Sep 30, 2020 Sep 30, 2019 Sep 30, 2018 Sep 30, 2017 Sep 30, 2016
No. shares of common stock outstanding1 284,023,582 290,031,363 270,459,892 268,257,940 227,978,328 212,319,588
Selected Financial Data (US$)
Shareholders’ equity (in millions) 23,677 23,765 21,081 20,994 12,948 7,633
Book value per share (BVPS)2 83.36 81.94 77.95 78.26 56.79 35.95
Share price1, 3 244.46 227.47 260.40 242.04 224.23 168.48
Valuation Ratio
P/BV ratio4 2.93 2.78 3.34 3.09 3.95 4.69
Benchmarks
P/BV Ratio, Competitors5
Abbott Laboratories 5.75 6.65 4.96
Cigna Group 1.53 1.46 1.49
CVS Health Corp. 1.83 1.33 1.47
Elevance Health Inc. 3.07 2.19 2.42
Humana Inc. 3.34 3.55 4.07
Intuitive Surgical Inc. 8.59 9.53 8.13
Medtronic PLC 3.26 2.48 2.66
UnitedHealth Group Inc. 6.27 4.83 4.92
P/BV Ratio, Sector
Health Care Equipment & Services 3.77 3.20 3.08
P/BV Ratio, Industry
Health Care 4.78 4.66 4.41

Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).

1 Data adjusted for splits and stock dividends.

2 2021 Calculation
BVPS = Shareholders’ equity ÷ No. shares of common stock outstanding
= 23,677,000,000 ÷ 284,023,582 = 83.36

3 Closing price as at the filing date of Becton, Dickinson & Co. Annual Report.

4 2021 Calculation
P/BV ratio = Share price ÷ BVPS
= 244.46 ÷ 83.36 = 2.93

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/BV ratio The P/BV ratio is interpreted as an indicator of market judgment about the relationship between a company required rate of return and its actual rate of return. Becton, Dickinson & Co. P/BV ratio decreased from 2019 to 2020 but then slightly increased from 2020 to 2021.